Intervention Protocol

Antipsychotics for people with persistent negative symptoms of schizophrenia

  1. Craig Whittington1,*,
  2. Thomas RE Barnes2,
  3. Tim Kendall3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 17 MAR 2010

DOI: 10.1002/14651858.CD008406


How to Cite

Whittington C, Barnes TRE, Kendall T. Antipsychotics for people with persistent negative symptoms of schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 3. Art. No.: CD008406. DOI: 10.1002/14651858.CD008406.

Author Information

  1. 1

    Research Department of Clinical, Education & Health Psychology, University College London, Centre for Outcomes Research and Effectiveness (CORE), London, UK

  2. 2

    Imperial College London, London, UK

  3. 3

    Royal College of Psychiatrists Research Unit, National Collaborating Centre for Mental Health, London, UK

*Craig Whittington, Centre for Outcomes Research and Effectiveness (CORE), Research Department of Clinical, Education & Health Psychology, University College London, Gower Street, London, WC1 6BT, UK. c.whittington@ucl.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 17 MAR 2010

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the clinical effects and safety of antipsychotic drugs in comparison with placebo or another antipsychotic drug in the treatment of people with persistent negative symptoms of schizophrenia and schizophrenia-like psychosis.